Kazia Therapeutics (KZIA) Current Assets (2009 - 2025)

Kazia Therapeutics has reported Current Assets for 15 years, with the latest figure at $46.0 million in Q4 2025.

• For the quarter ending Q4 2025, Current Assets rose 1962.6% year-over-year to $46.0 million; the trailing twelve-month figure through Dec 2025 stood at $46.0 million (up 1962.6% YoY), and the FY2025 full-year result was $3.2 million, down 21.99% from the prior year.
• Current Assets for Q4 2025 stood at $46.0 million, up from $3.2 million in the prior quarter.
• The five-year high for Current Assets was $46.0 million in Q4 2025, with the low at $2.2 million in Q4 2024.
• Historically, Current Assets has averaged $11.3 million across 5 years, with a median of $6.0 million in 2023.
• Annual changes were most pronounced in 2022 — Current Assets sank 70.1% — and 2025, when it surged 1962.6%.
• Kazia Therapeutics' Current Assets stood at $12.2 million in 2021, then tumbled by 68.07% to $3.9 million in 2022, then surged by 34.12% to $5.2 million in 2023, then slumped by 57.27% to $2.2 million in 2024, then surged by 1962.6% to $46.0 million in 2025.
• The last three Current Assets figures came in at $46.0 million (Q4 2025), $3.2 million (Q2 2025), and $2.2 million (Q4 2024), per Business Quant data.